Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122042) titled 'Prospective, Multicenter, Single-Arm Clinical Study on Eculizumab in the Treatment of Active ANCA-Associated Rapidly Progressive Glomerulonephritis' on April 8.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital, Zhejiang University School of Medicine

Condition: ANCA-Associated Rapidly Progressive Glomerulonephritis

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-15

Target Sample Size: Treatment Group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306377

Publis...